Covid-19: 68 new companies get FDCA permission to do HCQ
AHMEDABAD: An increasing number of companies are rushing to manufacture (HCQ), the antimalarial drug is widely used in the treatment of patients worldwide, and now also in India.
Gujarat's Food and (FDCA) issued permits to 68 pharmaceutical companies to manufacture HCQ tablets in the state. In the last month and a half, 68 pharmaceutical companies have received licenses for various-dose HCQ tablet products in Gujarat, said HG Koshia, commissioner of.
Companies like Sun Pharma, Intas Pharmaceuticals, Saga Lifesciences Limited, Norris Medicines, Ellis Pharmaceuticals, Jaimin Remedies, and Lincoln Pharma have received approvals to produce HCQ tablets.
In 60 years before the Covid-19 outbreak, Gujarat only had 28 companies that made HCQ tablets. The number has increased three times in less than two months. Now, the state has 96 players who make this drug, said Koshia.
HCQ is currently the most preferred drug in the management of Covid-19 worldwide, said Viranchi Shah, MD of Saga Lifesciences Limited.
India is a major source of HCQ supply and meets 70% of global requirements.